Value ‐Based Physician Payment in Oncology: Public and Private Insurer Initiatives

ConclusionsThe emerging “value‐based” methods of oncology payment supplement fee‐for‐service and cost‐based reimbursements with per‐month and per‐episode payments, but none of the payers bundle spending on cancer drugs with payments for other services. Payers recognize that bundled payment could create access barriers for patients and undermine innovation in effective but expensive new pharmaceuticals.
Source: The Milbank Quarterly - Category: Health Management Authors: Tags: Original Investigation Source Type: research